Anthony Bogachev Email & Phone Number

San Francisco Bay Area

Boston, Massachusetts, United States

First business advisor to a stealth-stage biotech company and the two co-founding PhD students. Technology licensed from Harvard Medical School.Selected as a participant in the Nucleate Activator 2024 incubator programFinalist in the Nucleate Activator Final Pitch CompetitionSemi-Finalist in the Harvard President's Innovation Challenge

San Francisco Bay Area

JJDC is J&J's corporate venture capital (CVC) group. Diligenced early-stage biotech investment opportunities, created scientific and financial presentation materials for the investment committee, and performed a retrospective analysis of past investments.

Cambridge, Massachusetts, United States

Roivant Social Ventures is Roivant's venture philanthropy 501(c)(3) organization focused on improving access to healthcare. Evaluated investment opportunities and supported existing partnerships.Publication: https://www.nature.com/articles/d41586-022-02803-8

New York, New York, United States

New York, New York, United States

Sumitovant was a Roivant Sciences spinout. Now part of Sumitomo Pharma America. Created a company-wide technology roadmap and financial model for the C-suite.

New York, New York, United States

Roivant is a healthcare platform company that launches biotechnology and healthtech subsidiary companies. Through the company's 2-year rotational program, I worked both at the platform level and within the portfolio companies.

New York, New York, United States

Immunovant is a Roivant subsidiary developing a monoclonal antibody to treat IgG-mediated autoimmune diseases. Worked directly with the ClinOps, BusOps, Manufacturing, and Quality teams.

New York, New York, United States

Roivant Health is the company's internal incubator for new ventures. Worked on the ideation, market research, and early stage development of multiple biotech and healthtech business opportunities.

Philadelphia, Pennsylvania, United States

Spirovant is an ex-Roivant subsidiary (now under Sumitomo Pharma America) developing gene therapies for Cystic Fibrosis and other pulmonary diseases. Supported new company operations as one of the first 10 employees.

Greater Boston Area

Strategy consulting for biopharma clients.

Cambridge, MA

Wearable soft robotics for patients with reduced muscular function.

Greater Minneapolis-St. Paul Area

X-ray crystallography wet lab and computational research.

Mba

Part of the dual degree MS/MBA Biotechnology program. Graduated MBA with Distinction (<15% of the MBA class). Authored the technical note.

Master Of Science, Biotechnology

Part of the dual degree MS/MBA Biotechnology program. The MS program is joint between the Harvard Graduate School of Arts and Sciences and.

S.B. Bioengineering; Secondary In Global Health And Health Policy; Cum Laude

Leadership roles in Engineers Without Borders, MakeHarvard, International Relations Council